Transparency Sought From FDA In GRAS Notification Filing Decisions
This article was originally published in The Tan Sheet
Executive Summary
FDA should clarify its criteria for rejecting generally recognized as safe notifications for food ingredients voluntarily submitted by companies, a consulting firm tells the agency.